PTC Therapeutics, Inc. (PTCT)
62.82
-0.51
(-0.81%)
USD |
NASDAQ |
Mar 06, 16:00
62.99
+0.17
(+0.27%)
After-Hours: 20:00
PTC Therapeutics Cash from Investing (Quarterly) : 34.01M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -6.494M |
| Insmed, Inc. | 389.41M |
| Sarepta Therapeutics, Inc. | 96.21M |
| Keros Therapeutics, Inc. | -0.134M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -34.27M |
| Cash from Financing (Quarterly) | 302.50M |
| Free Cash Flow | 411.18M |
| Free Cash Flow Per Share (Quarterly) | -0.8869 |
| Free Cash Flow to Equity (Quarterly) | -60.14M |
| Free Cash Flow to Firm (Quarterly) | -18.01M |
| Free Cash Flow Yield | 7.88% |